We are monitoring the impact of COVID-19 on Injectable Drug Delivery Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2015
Share on
Share on

Global Injectable Drug Delivery Market Analysis – By Device Type (Self-Injection Devices, Conventional Devices), Formulation (Conventional Drug Delivery, Novel Drug Delivery), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), End User (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), Region - Industry Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: February, 2020
ID: 2015
Pages: 175

Injectable Drug Delivery Market Size & Growth (2019 - 2024)

The size of the Global Injectable Drug Delivery Market was worth USD 4484.5 million in 2019 and estimated to be growing at a CAGR of 11.5%, to reach USD 67846.3 million by 2024 during the forecast period 2019 - 2024.

Injectable drug delivery technologies allow the transport of drugs detailed in fluid form and encourage the fast transport of the drug into the body. It likewise helps in managing drugs in comatose and unconscious patients. These delivery frameworks are generally accepted because of their recognition of a faster onset reaction with high adequacy. Also, in recent years, this market has developed because of the expanded predominance of cancer and diabetes.

The key factors driving the Injectable Drug Delivery Market are increased prevalence of chronic diseases, technological advances in the form of nanotechnologies, rising demand for biologics in the pharmaceutical industry and increased patient compliance.

The restraining factors affecting the Injectable Drug Delivery (IDD) market include the Possibility of injuries and infections via usage, Product recalls, Emergence of alternative drug delivery systems, Regulatory framework concerns.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Device Type, Formulation, Therapeutic Use, End User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Analysed

Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation and West Pharmaceutical Inc.

 

This research report on the Global Injectable Drug Delivery Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Injectable Drug Delivery Market - By Device Type:

  • Self-Injection Devices
  • Conventional Devices

Injectable Drug Delivery Market - By Formulation:

  • Conventional Drug Delivery
  • Novel Drug Delivery

Injectable Drug Delivery Market - By Therapeutic Use:

  • Autoimmune Disorders
  • Hormonal Disorders
  • Oncology

Injectable Drug Delivery Market - By End User:

  • Hospitals
  • Homecare Settings
  • Research Institutes
  • Clinical Laboratories

Regional Analysis:

Injectable Drug Delivery Market was dominated by North America, with the overall market share of over 35% globally. North America was followed by Europe and Asia-Pacific. The Asia Pacific is predicted to grow at a rapid pace in the coming few years.

Companies dominating the Global Injectable Drug Delivery Market profiled in the report are:

  1. Alkermes Inc.
  2. Bend Research
  3. BIND Biosciences, Inc.
  4. Endocyte
  5. Genentech Inc.
  6. MicroCHIPS, Inc.
  7. Pearl Therapeutics Inc.
  8. Polymer Factory
  9. Presage Bioscience
  10. QLT Inc.
  11. UCB Group

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Device Type                               

                                5.1.1 Introduction           

                                5.1.2 Self-injection Devices         

                                5.1.3  Conventional Devices        

                                5.1.4  Y-o-Y Growth Analysis, By Device Type      

                                5.1.5  Market Attractiveness Analysis, By Device Type    

                                5.1.6  Market Share Analysis, By Device Type     

                5.2 Formulation                               

                                5.2.1 Introduction           

                                5.2.2 Conventional Drug Delivery             

                                5.2.3  Novel Drug Delivery           

                                5.2.4 Y-o-Y Growth Analysis, By Formulation       

                                5.2.5 Market Attractiveness Analysis, By Formulation     

                                5.2.6 Market Share Analysis, By Formulation      

                5.3 Therapeutic Use                       

                                5.3.1 Introduction           

                                5.3.2 Autoimmune Disorders     

                                5.3.3 Hormonal Disorders            

                                5.3.4 Oncology 

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use              

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Use           

                                5.3.7  Market Share Analysis, By Therapeutic Use             

                5.4 End-user                              

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Homecare Settings              

                                5.4.4 Research Institutes             

                                5.4.5 Clinical Laboratories            

                                5.4.6 Other        

                                5.4.7 Y-o-Y Growth Analysis, By End-user

                                5.4.8  Market Attractiveness Analysis, By End-user

                                5.4.9  Market Share Analysis, By End-user

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Device Type

                                                6.1.3.3 By Formulation

                                                6.1.3.4 By Therapeutic Use

                                                6.1.3.5 By End-user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Device Type

                                                6.1.4.3 By Formulation

                                                6.1.4.4 By Therapeutic Use

                                                6.1.4.5 By End-user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Device Type

                                                6.1.5.3 By Formulation

                                                6.1.5.4 By Therapeutic Use

                                                6.1.5.5 By End-user

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Alkermes Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Bend Research                          

                8.3 BIND Biosciences Inc.                             

                8.4 Endocyte                     

                8.5 Genentech Inc.                         

                8.6 MicroCHIPS Inc.                        

                8.7 Pearl Therapeutics Inc.                          

                8.8 Polymer Factory                       

                8.9 Presage Bioscience                 

                8.10  QLT Inc.                     

                8.11 UCB Group.                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Injectable Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  2. Global Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  3. Global Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  4. Global Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  5. Global Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  6. Global Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  7. Global Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  8. Global Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  9. Global Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  10. Global Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  11. Global Oncology Market By Region, From 2019-2024 ( USD Million )
  12. Global Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  13. Global Hospitals Market By Region, From 2019-2024 ( USD Million )
  14. Global Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  15. Global Research Institutes Market By Region, From 2019-2024 ( USD Million )
  16. Global Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  17. North America Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  18. North America Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  19. North America Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  20. North America Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  21. North America Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  22. North America Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  23. North America Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  24. North America Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  25. North America Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  26. North America Oncology Market By Region, From 2019-2024 ( USD Million )
  27. North America Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  28. North America Hospitals Market By Region, From 2019-2024 ( USD Million )
  29. North America Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  30. North America Research Institutes Market By Region, From 2019-2024 ( USD Million )
  31. North America Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  32. United States Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  33. United States Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  34. United States Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  35. United States Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  36. Canada Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  37. Canada Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  38. Canada Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  39. Canada Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  40. Europe Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  41. Europe Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  42. Europe Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  43. Europe Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  44. Europe Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  45. Europe Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  46. Europe Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  47. Europe Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  48. Europe Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  49. Europe Oncology Market By Region, From 2019-2024 ( USD Million )
  50. Europe Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  51. Europe Hospitals Market By Region, From 2019-2024 ( USD Million )
  52. Europe Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  53. Europe Research Institutes Market By Region, From 2019-2024 ( USD Million )
  54. Europe Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  55. U.K. Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  56. U.K. Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  57. U.K. Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  58. U.K. Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  59. Germany Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  60. Germany Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  61. Germany Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  62. Germany Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  63. France Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  64. France Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  65. France Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  66. France Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  67. Italy Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  68. Italy Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  69. Italy Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  70. Italy Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  71. Spain Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  72. Spain Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  73. Spain Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  74. Spain Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  75. Asia-Pacific Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  76. Asia-Pacific Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  77. Asia-Pacific Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  78. Asia-Pacific Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  79. Asia-Pacific Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  80. Asia-Pacific Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  81. Asia-Pacific Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  82. Asia-Pacific Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  83. Asia-Pacific Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  84. Asia-Pacific Oncology Market By Region, From 2019-2024 ( USD Million )
  85. Asia-Pacific Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  86. Asia-Pacific Hospitals Market By Region, From 2019-2024 ( USD Million )
  87. Asia-Pacific Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  88. Asia-Pacific Research Institutes Market By Region, From 2019-2024 ( USD Million )
  89. Asia-Pacific Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  90. Japan Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  91. Japan Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  92. Japan Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  93. Japan Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  94. China Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  95. China Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  96. China Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  97. China Injectable Drug Delivery Market By End-user, From 2019-2024 ( USD Million )
  98. India Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  99. India Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  100. India Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  101. India Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  102. Australia Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  103. Australia Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  104. Australia Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  105. Australia Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  106. South Korea Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  107. South Korea Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  108. South Korea Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  109. South Korea Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  110. Latin America Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  111. Latin America Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  112. Latin America Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  113. Latin America Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  114. Latin America Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  115. Latin America Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  116. Latin America Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  117. Latin America Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  118. Latin America Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  119. Latin America Oncology Market By Region, From 2019-2024 ( USD Million )
  120. Latin America Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  121. Latin America Hospitals Market By Region, From 2019-2024 ( USD Million )
  122. Latin America Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  123. Latin America Research Institutes Market By Region, From 2019-2024 ( USD Million )
  124. Latin America Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  125. Brazil Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  126. Brazil Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  127. Brazil Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  128. Brazil Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  129. Argentina Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  130. Argentina Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  131. Argentina Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  132. Argentina Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  133. Mexico Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  134. Mexico Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  135. Mexico Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  136. Mexico Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  137. Rest of Latin America Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  138. Rest of Latin America Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  139. Rest of Latin America Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  140. Rest of Latin America Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  141. Middle East & Africa Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  142. Middle East & Africa Self-injection Devices Market By Region, From 2019-2024 ( USD Million )
  143. Middle East & Africa Conventional Devices Market By Region, From 2019-2024 ( USD Million )
  144. Middle East & Africa Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  145. Middle East & Africa Conventional Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  146. Middle East & Africa Novel Drug Delivery Market By Region, From 2019-2024 ( USD Million )
  147. Middle East & Africa Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  148. Middle East & Africa Autoimmune Disorders Market By Region, From 2019-2024 ( USD Million )
  149. Middle East & Africa Hormonal Disorders Market By Region, From 2019-2024 ( USD Million )
  150. Middle East & Africa Oncology Market By Region, From 2019-2024 ( USD Million )
  151. Middle East & Africa Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  152. Middle East & Africa Hospitals Market By Region, From 2019-2024 ( USD Million )
  153. Middle East & Africa Homecare Settings Market By Region, From 2019-2024 ( USD Million )
  154. Middle East & Africa Research Institutes Market By Region, From 2019-2024 ( USD Million )
  155. Middle East & Africa Clinical Laboratories Market By Region, From 2019-2024 ( USD Million )
  156. Middle East Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  157. Middle East Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  158. Middle East Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  159. Middle East Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )
  160. Africa Injectable Drug Delivery Market By Device Type , From 2019-2024 ( USD Million )
  161. Africa Injectable Drug Delivery Market By Formulation, From 2019-2024 ( USD Million )
  162. Africa Injectable Drug Delivery Market By Therapeutic Use, From 2019-2024 ( USD Million )
  163. Africa Injectable Drug Delivery Market By End-user , From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample